Parkin variants in North American Parkinson's disease: Cases and controls

Movement Disorders

Volumn 18, Issue 11, 2003, Pages 1306-1311

  Lincoln, Sarah J ^a   Maraganore, Demetrius M ^b   Lesnick, Timothy G ^b   Bounds, Rebecca ^a   de Andrade, Mariza ^b   Bower, James H ^b   Hardy, John A ^a   Farrer, Matthew J ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC ROCHESTER   (United States)

Author keywords

North America; Parkin; Parkinson's disease; V380L

Indexed keywords

PARKIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EXON; FAMILY HISTORY; FEMALE; GENE DELETION; GENE DUPLICATION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HETEROZYGOSITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOZYGOSITY; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NORTH AMERICA; PARKINSON DISEASE; PATHOGENICITY; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMOSOME MAPPING; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE DELETION; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; UBIQUITIN-PROTEIN LIGASES; UNITED STATES;

EID: 1342347411     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10601     Document Type: Article

References (41)

1. Ishikawa A, Takahashi H. Clinical and neuropathological aspects of autosomal recessive juvenile parkinsonism. J Neurol 1998;245: 4-9.
2. Yamamura Y, Arihiro K, Kohriyama T, Nakamura S. Early-onset parkinsonism with diurnal fluctuation - clinical and pathological studies. Rinsho Shinkeigaku 1993;33:491-496.
3. Mori H, Kondo T, Yokochi M, et al. Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q. Neurology 1998;51:890-892.
4. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392:605-608.
5. Shimura H, Hattori N, Kubo S, et al. Familial parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet 2000;25:302-305.
6. Hattori N, Kitada T, Matsumine H, et al. Molecular genetic analysis of a novel parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the parkin gene in affected individuals. Ann Neurol 1998;44:35-41.
7. Hattori N, Matsumine H, Asakawa S, et al. Point mutations (Thr240Arg and Gln311Stop) [correction of Thr240Arg and Ala311Stop] in the parkin gene. Biochem Biophys Res Commun 1998;249:754-758.
8. Bonifati V, Lucking CB, Fabrizio E, Periquet M, Meco G, Brice A. Three parkin gene mutations in a sibship with autosomal recessive early onset parkinsonism. J Neurol Neurosurg Psychiatry 2001;71: 531-534.
9. Nisipeanu P, Inzelberg R, Blumen SC, et al. Autosomal-recessive juvenile parkinsonism in a Jewish Yemenite kindred: mutation of parkin gene. Neurology 1999;53:1602-1604.
10. Munoz E, Pastor P, Marti MJ, Oliva R, Tolosa E. A new mutation in the parkin gene in a patient with atypical autosomal recessive juvenile parkinsonism. Neurosci Lett 2000;289:66-68.
11. Wu R, Shan D, Sun C, et al. Clinical, [18F]-Dopa PET and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutations. Mov Disord 2002;17:670-675.
12. Abbas N, Lucking CB, Ricard S, et al A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Hum Mol Genet 1999;8:567-574.
13. Lucking C, Abbas N, Durr A, et al. Homozygous deletions in the parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. The European Consortium on Genetic Susceptibility in Parkinson's Disease and the French Parkinson's Disease Genetics Study Group. Lancet 1998;352:1355-1356.
14. Klein C, Pramstaller PP, Kis B, Page CC, et al. Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann Neurol 2001;48:65-71.
15. Periquet M, Lucking C, Vaughan J, et al. Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from founder effects. Am J Hum Genet 2001;68:617-626.
16. Nichols WC, Pankratz N, Uniacke SK, et al. Linkage stratification and mutation analysis at the Parkin locus identifies mutation positive Parkinson's disease families. J Med Genet 2002;39:489-492
17. Pineda-Trujillo N, Carvajal-Carmona LG, Buritica O, et al. A novel Cys212Tyr founder mutation in parkin and allelic heterogeneity of juvenile parkinsonism in a population from North West Colombia. Neurosci Lett 2000;298:87-90.
18. Terreni L, Calabrese E, Calella AM, Forloni G, Mariani C. New mutation (R42P) of the parkin gene in the ubiquitin-like domain associated with parkinsonism. Neurology 2001;56:463-466.
19. Alvarez V, Guisasola L, Moreira V, Lahoz C, Coto E. Early-onset Parkinson's disease associated with a new parkin mutation in a Spanish family. Neurosci Lett 2001;313:108-110.
20. Hedrich K, Kann M, Lanthaler AJ, et al. The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. Hum Mol Genet 2001;10:1649-1656.
21. Foroud T, Uniacke SK, Liu L, et al. Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease. Neurology 2003;60:796-801.
22. Leroy E, Anastasopoulos D, Konitsiotis S, Lavedan C, Polymeropoulos MH. Deletions in the parkin gene and genetic heterogeneity in a Greek family with early onset Parkinson's disease. Hum Genet 1998;103:424-427.
23. Lucking CB, Bonifati V, Periquet M, Vanacore N, Brice A, Meco G. Pseudo-dominant inheritance and exon 2 triplication in a family with parkin gene mutations. Neurology 2001;57:924-927.
24. Maruyama M, Ikeuchi T, Saito M, et al. Novel mutations, pseudo-dominant inheritance, and possible familial affects in patients with autosomal recessive juvenile parkinsonism. Ann Neurol 2000;48: 245-250.
25. Farrer M, Chan P, Chen R, Tan L, et al. Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol 2001;50: 293-300.
26. West A, Periquet M, Lincoln S, et al. The complex relationship between parkin mutations and Parkinson's disease. Am J Med Genet 2002;114:584-591.
27. West A, Farrer M, Petrucelli L, Cookson M, Lockhart P, Hardy J. Identification and characterization of the human parkin gene promoter. J Neurochem 2001;78:1146-1152.
28. Asakawa S, Tsunematsu K, Takayanagi A, et al. The genomic structure and promoter region of the human parkin gene. Biochem Biophys Res Commun 2001;286:863-868.
29. Maraganore DM, Farrer MJ, Hardy JA, et al. Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson's disease. Neurology 1999;53:1858-1860.
30. Maraganore DM, Farrer MJ, Hardy JA, et al. Case-control study of debrisoquine 4-hydroxylase, N-acetyltransferase 2, and apolipoprotein E gene polymorphisms in Parkinson's disease. Mov Disord 2000;15:714-719.
31. Maraganore DM, Hernandez DG, Singleton AB, et al. Case-control study of the extended tau gene haplotype in Parkinson's disease. Ann Neurol 2001;50:658-661.
32. Hilker R, Klein C, Ghaemi M, et al. Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol 2001;49:367-376.
33. Rischewski J, Schneppenheim R. Screening strategies for a highly polymorphic gene: DHPLC analysis of the Fanconi anemia group A gene. J Biochem Biophys Methods 2001;47:53-64.
34. Goudreau JL, Maraganore DM, Farrer MJ, et al. Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease. Mov Disord 2002;17:1305-1311.
35. Satoh J, Kuroda Y. Association of codon 167 Ser/Asn heterozygosity in the parkin gene with sporadic Parkinson's disease. Neuroreport 1999;10:2735-2739.
36. Wang M, Hattori N, Matsumine H, et al. Polymorphism in the parkin gene in sporadic Parkinson's disease. Ann Neurol 1999;45: 655-658.
37. Klein C, Schumacher K, Jacobs H, et al. Association studies of Parkinson's disease and parkin polymorphisms. Ann Neurol 2000; 48:126-127.
38. Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N Engl J Med 2000;342:1560-1567.
39. Mellick GD, Buchanan DD, Hattori N, et al. The parkin gene S/N167 polymorphism in Australian Parkinson's disease patients and controls. Parkinsonism Relat Disord 2001;7:89-91.
40. Kann M, Jacobs H, Mohrmann K, et al. Role of parkin mutations in 111 community-based patients with early-onset parkinsonism. Ann Neurol 2002;51:621-625.
41. Oliveri RL, Zappia M, Annesi G, et al. The parkin gene is not involved in late-onset Parkinson's disease. Neurology 2001;57: 359-362.